Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penson

Showing results (611-620 of 1,177) with videos related to

Pageof 118
Sort By:
Heart & Lung : the Journal of Critical Care|May 3, 2022
Risk factors for post sternotomy wound complications across the patient journey: A systematised review of the literatureN Morrell Scott, R R Lotto, E Spencer, et al.
Drug Safety|October 7, 2019
Adverse Events Associated with Cumulative Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims AnalysisNeil M Schultz, David F Penson, Samuel Wilson, et al.
Tissue Engineering. Part A|May 29, 2015
Gas Transfer in Cellularized Collagen-Membrane Gas Exchange DevicesJustin H Lo, Erik K Bassett, Elliot J N Penson, et al.
Foods (Basel, Switzerland)|April 16, 2020
Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in BahrainHaitham Jahrami, Mana Al-Mutarid, Peter E Penson, et al.
The Journal of Urology|March 12, 2003
Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data baseDavid F Penson, David M Latini, Deborah P Lubeck, et al.
Progress in Cardiovascular Diseases|December 31, 2020
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitorsBarbara Cybulska, Longina Kłosiewicz-Latoszek, Peter E Penson, et al.
Family & Community Health|December 17, 2010
Racial and ethnic approaches to community health: reducing health disparities by addressing social determinants of healthJoyce Buckner-Brown, Pattie Tucker, Mark Rivera, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancerD F Penson, M S Litwin, D P Lubeck, et al.
Drug Discovery Today|September 17, 2019
A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposomeNasim Kiaie, Armita Mahdavi Gorabi, Peter E Penson, et al.
Journal of Managed Care & Specialty Pharmacy|June 8, 2019
Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims AnalysisNeil M Schultz, David F Penson, Samuel D Wilson, et al.
Pageof 118

Showing results (611-620 of 1,177) with videos related to

Sort By:
Pageof 118
Heart & Lung : the Journal of Critical Care|May 3, 2022
Risk factors for post sternotomy wound complications across the patient journey: A systematised review of the literatureN Morrell Scott, R R Lotto, E Spencer, et al.
Drug Safety|October 7, 2019
Adverse Events Associated with Cumulative Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims AnalysisNeil M Schultz, David F Penson, Samuel Wilson, et al.
Tissue Engineering. Part A|May 29, 2015
Gas Transfer in Cellularized Collagen-Membrane Gas Exchange DevicesJustin H Lo, Erik K Bassett, Elliot J N Penson, et al.
Foods (Basel, Switzerland)|April 16, 2020
Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in BahrainHaitham Jahrami, Mana Al-Mutarid, Peter E Penson, et al.
The Journal of Urology|March 12, 2003
Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data baseDavid F Penson, David M Latini, Deborah P Lubeck, et al.
Progress in Cardiovascular Diseases|December 31, 2020
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitorsBarbara Cybulska, Longina Kłosiewicz-Latoszek, Peter E Penson, et al.
Family & Community Health|December 17, 2010
Racial and ethnic approaches to community health: reducing health disparities by addressing social determinants of healthJoyce Buckner-Brown, Pattie Tucker, Mark Rivera, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancerD F Penson, M S Litwin, D P Lubeck, et al.
Drug Discovery Today|September 17, 2019
A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposomeNasim Kiaie, Armita Mahdavi Gorabi, Peter E Penson, et al.
Journal of Managed Care & Specialty Pharmacy|June 8, 2019
Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims AnalysisNeil M Schultz, David F Penson, Samuel D Wilson, et al.
Pageof 118